Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is recommended as prophylaxis against Pneumocystis pneumonia (PCP) in renal transplant recipients. The optimal duration of prophylaxis is unknown. Longer duration of prophylaxis may increase the risk of adverse effects. The aim of this retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Fiona A., Dickerson, Jonathan E., Daly, Conal, Clancy, Marc, Geddes, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918803/
https://www.ncbi.nlm.nih.gov/pubmed/31806862
http://dx.doi.org/10.12659/AOT.918195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918803/
https://www.ncbi.nlm.nih.gov/pubmed/31806862
http://dx.doi.org/10.12659/AOT.918195

Ejemplares similares